The Trump administration just made another big move to reshape the healthcare system

Business Insider, February 20, 2018
Bob Bryan, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: "Short-term insurance plans will cherry pick healthy people, leaving ACA-compliant plans to cover a sicker pool with higher premiums," Levitt tweeted. "With the expansion in short-term insurance plans, low-income people will be protected from higher…

Read More

A Framework for Ethical Payment to Research Participants

NEJM, February 22, 2018
Luke Gelinas (Clinical Research Ethics Fellow), Emily A. Largent (Student Fellow Alumna), I. Glenn Cohen (Faculty Director), Susan Kornetsky, Barbara

Members of the Petrie-Flom Center's collaboration with the Regulatory Foundations, Ethics, and Law Program of Harvard Catalyst | The Harvard Clinical and Translational Science Center at Harvard…

Read More

Weinstein Sued By New York Attorney General

Bloomberg, February 14, 2018
David Sucherman, interviewing Jennifer Drobac (Visiting scholar)

"From the article"  Jennifer Ann Drobac, a professor at Harvard University Law School, discusses a new lawsuit against Harvey Weinstein that was brought by New York attorney general Eric Schniederman over the sale of his company, Weinstein Co. She speaks with…

Read More

Trump fires first salvo on drug prices

The Hill, February 12, 2018
Peter Sullivan, referencing Rachel Sachs (Academic Fellow Alumna)

From the article: President Trump is beginning to move on high drug prices, unveiling a series of modest proposals in his budget request released Monday. It’s the first time Trump has issued major proposals to lower drug prices…

Read More

Trump teams rolls out new drug pricing ideas

Politico, February 12, 2018
Sarah Karlin-Smith, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: TRUMP TEAM TAKES ANOTHER STAB AT DRUG PRICES: ARE THEY SERIOUS THIS TIME? — Late last week came two new signs the White House may finally be ready to move beyond rhetoric on drug prices. Details began to trickle out about drug pricing…

Read More

Budget, White Paper Provide Insight Into Trump Administration’s Strategy On Drug Pricing

Health Affairs, February 12, 2018
Rachel Sachs (Academic Fellow Alumna)

From the article: During his first year in office, President Donald Trump spoke often about the problem of high drug prices but took no action on the subject. President Trump’s new budget proposal and a newly released white paper from the…

Read More

Hundreds sign on to letter opposing ‘right to try’ drug bill

The Hill , February 5, 2018
Rachel Roubein, reporting on Holly Fernandez Lynch (Former Executive Director and Academic Fellow Alumna)

From the Article:  Several hundred "right to try" critics sent a letter to House Energy and Commerce Committee leaders expressing their “strong opposition” to the bill President Trump urged Congress to pass in his State of…

Read More

Physicians, ethicists urge Congress not to pass ‘right-to-try’ legislation

Stat, February 1, 2018
Ike Swetlitz, reporting on Holly Fernandez Lynch (Former Executive Director and Academic Fellow Alumna)

From the article: Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health.

Read More

The Future of Healthcare Could Be a Privacy Nightmare

Tonic Vice, February 8, 2018
Susan Rinkunas, quoting I. Glenn Cohen (Faculty Director)

From the article: If Amazon had that authorization, it would be able to use people’s health information to nudge them toward specific products, says I. Glenn Cohen, a Harvard Law School professor who specializes in health law policy and editor of the forthcoming…

Read More

White House Calls to Expedite Review of 2nd or 3rd Classes of New Molecular Entities

Regulatory Focus, February 09, 2018
Zachary Brennan, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: The White House's Council of Economic Advisers on Friday released a report on drug pricing, suggesting changes to the Medicare and Medicaid programs and reforming the US Food and Drug Administration (FDA) could encourage more robust price competition. …

Read More

Can Healthcare Avoid “Black Box” Artificial Intelligence Tools?

Health IT Analytics, February 2, 2018
Jennifer Bresnick, quoting I. Glenn Cohen (Faculty Director) and W. Nicholson Price II (Academic Fellow Alumnus)

From the article: Artificial intelligence is taking the healthcare industry by storm as researchers share breakthrough after breakthrough and vendors quickly commercialize advanced algorithms offering clinical decision support or financial and operational aid. …

Read More

Harvard Law to Explore Legal Complexities of Precision Medicine, AI

Healthcare Analytics News, February 1, 2018
Ryan Black, featuring the Project on Precision Medicine, Artificial Intelligence, and the Law (PMAIL)

From the article: Precision medicine and artificial intelligence (AI) are complicated by design: Both scientific fields rely on extreme specificity, complex equations, and forces that can’t be seen. As both fields begin to alter the healthcare landscape,…

Read More

Trump’s abandoned promise to bring down drug prices, explained

Vox, February 2, 2018
Dylan Scott, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: One year into Donald Trump’s presidency, as he delivered his first State of the Union address, he has more or less abandoned his outspoken pledges to bring down the cost of America’s medicines, the highest in the world.

Read More

Four ethicists walk into a Super Bowl party

The Outline, February 1, 2018
Ann-Derrick Gaillot, interviewing I. Glenn Cohen (Faculty Director)

From the article: It’s not easy to feel good watching the NFL. CTE may or may not be destroying players’ lives as they play their hearts out for the fans. Black players’ peaceful protests on against racial injustice are being crucified by everyone…

Read More

Privacy experts alarmed as Amazon moves into the health care industry

Washington Post, January 30, 2018
Abha Bhattarai, quoting I. Glenn Cohen (Faculty Director)

From the article: Amazon.com on Tuesday announced a joint partnership with Berkshire Hathaway and JP Morgan to create an independent health-care company for their employees, putting an end to months of speculation that the technology giant was eyeing…

Read More

Physicians, ethicists urge Congress not to pass ‘right to try’ legislation

STAT News, February 1, 2018
Ike Swetlitz reporting on Holly Fernandez Lynch (Former Executive Director and Academic Fellow Alumna)

From the article: Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health.

Read More

Trump Pledges To Lower Drug Costs — Can We Do It?

NPR, January 31, 2018
Anthony Brooks, interviewing Rachel Sachs (Academic Fellow Alumna)

From the podcast: President Trump says in his State of the Union that going after the high cost of prescription drugs is a top priority. Politicians have promised for years to bring them down. We’ll examine his medical checklist, and the prospects for fixing…

Read More

Petrie-Flom Center launches Project on Precision Medicine, Artificial Intelligence, and the Law

Harvard Law Today, January 31, 2018
Q & A with I. Glenn Cohen (Faculty Director)

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen recently announced a new collaboration, the Project on Precision Medicine, Artificial…

Read More

PFC Spotlight: Academic Fellow Alumnus Matthew J. B. Lawrence

Petrie-Flom Center , January 31, 2018

Matthew J. B. Lawrence was an Academic Fellow from 2010-2013, during which time his research focused on health care reform and health insurance coverage…

Read More

The Petrie-Flom Center Launches the Innovative Funding Models in Translational Research Project

The Petrie-Flom Center, January 29, 2018

January 30, 2018 - The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is launching the

Read More